<DOC>
	<DOCNO>NCT01446497</DOCNO>
	<brief_summary>Purpose To evaluate efficacy safety combigan ( Brimonidine/Timolol ) 0.5 % Timoptic ( Timolol ) ophthalmic solution normal tension glaucoma patient .</brief_summary>
	<brief_title>Efficacy Safety Study Combigan 0.5 % Timoptic Normal Tension Glaucoma</brief_title>
	<detailed_description>- Normal tension glaucoma ( NTG ) major type glaucoma Korea . ( 90 % glaucoma type ) - Brimonidine ( selective alpha 2 adrenergic agonist ) : neuroprotection effect suppression aqueous humor production increasement uveoscleral outflow - Timolol ( non selective beta blocker ) : suppression effect aqueous humor production - Combigan ( fix combination brimonidine &amp; timolol ) : lower effect intraocular pressure enhance compliance glaucoma patient</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Low Tension Glaucoma</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>18 year old baseline IOP 22 mmHg , anterior chamber angle &gt; Grade 3~4 Shaffer grade system IOP 22 mmHg Goldmann applanation tonometer type glaucoma except open angle IOP lower treatment chronic recurrent Hx . ocular inflammation use contact lens ocular disease could affect visual field examination ( diabetic retinopathy , macular disease , uveitis , scleritis , optic neuritis , anterior ischemic optic neuropathy ) intraocular glaucoma surgery within 6 month Hx . allergic reaction timolol brimonidine bronchial asthma moderate severe chronic obstructive pulmonary disease heart failure 2~3 degree AV block , MAO inhibitor use anti depressant use untreated pheochromocytoma pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Normal tension glaucoma</keyword>
	<keyword>Antiglaucoma ophthalmic solution</keyword>
	<keyword>Brimonidine</keyword>
	<keyword>Timolol</keyword>
	<keyword>Combination drug</keyword>
</DOC>